SLC46A3 inhibitors are a class of chemical compounds designed to specifically target and block the activity of the **SLC46A3** protein, a member of the solute carrier (SLC) family involved in the transport of various molecules across cellular membranes. SLC46A3 belongs to the SLC46 family, which includes transporters primarily associated with folate and other essential nutrient uptake. SLC46A3 is believed to facilitate the movement of certain molecules, such as folates or other organic compounds, across cell membranes, which is critical for maintaining nutrient balance and cellular function. By inhibiting SLC46A3, these compounds disrupt the normal transport of these molecules, leading to alterations in cellular nutrient availability and related metabolic pathways.
The study of SLC46A3 inhibitors provides valuable insights into the role of this transporter in cellular metabolism, particularly in how it influences the uptake and utilization of vital nutrients. When SLC46A3 function is inhibited, researchers can investigate how disruptions in nutrient transport affect cellular processes such as energy production, biosynthesis, and metabolic regulation. Inhibitors of SLC46A3 allow scientists to explore the transporter's interactions with other molecular pathways, shedding light on its broader role in maintaining cellular homeostasis. Additionally, these inhibitors offer a tool to examine how nutrient transport systems are regulated in response to environmental changes and how their dysfunction may impact cellular function. By blocking SLC46A3, researchers can better understand the intricate balance between nutrient transport and metabolism, further revealing the significance of SLC proteins in supporting essential cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker, affecting calcium transport across cell membranes. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Inhibits sodium channels and transporters, affecting sodium balance and transport. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+-ATPase, affecting ion balance and transport across membranes. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
A carbonic anhydrase inhibitor, used for various conditions involving ion transport. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing SLC46A3. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect SLC46A3-related pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SLC46A3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways, potentially affecting SLC46A3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||